Oncogenic Extrachromosomal DNA Functions As Mobile Enhancers to Globally Amplify Chromosomal Transcription
Overview
Authors
Affiliations
Extrachromosomal, circular DNA (ecDNA) is emerging as a prevalent yet less characterized oncogenic alteration in cancer genomes. We leverage ChIA-PET and ChIA-Drop chromatin interaction assays to characterize genome-wide ecDNA-mediated chromatin contacts that impact transcriptional programs in cancers. ecDNAs in glioblastoma patient-derived neurosphere and prostate cancer cell cultures are marked by widespread intra-ecDNA and genome-wide chromosomal interactions. ecDNA-chromatin contact foci are characterized by broad and high-level H3K27ac signals converging predominantly on chromosomal genes of increased expression levels. Prostate cancer cells harboring synthetic ecDNA circles composed of characterized enhancers result in the genome-wide activation of chromosomal gene transcription. Deciphering the chromosomal targets of ecDNAs at single-molecule resolution reveals an association with actively expressed oncogenes spatially clustered within ecDNA-directed interaction networks. Our results suggest that ecDNA can function as mobile transcriptional enhancers to promote tumor progression and manifest a potential synthetic aneuploidy mechanism of transcription control in cancer.
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC.
Fiorini E, Malinova A, Schreyer D, Pasini D, Bevere M, Alessio G Nature. 2025; .
PMID: 40074906 DOI: 10.1038/s41586-025-08721-9.
Three-dimensional regulatory hubs support oncogenic programs in glioblastoma.
Breves S, Di Giammartino D, Nicholson J, Cirigliano S, Mahmood S, Lee U bioRxiv. 2025; .
PMID: 40034649 PMC: 11875237. DOI: 10.1101/2024.12.20.629544.
Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies.
Yang J, Zhou F, Luo X, Fang Y, Wang X, Liu X Cell Death Discov. 2025; 11(1):84.
PMID: 40032852 PMC: 11876437. DOI: 10.1038/s41420-025-02366-3.
BRCA1-A and LIG4 complexes mediate ecDNA biogenesis and cancer drug resistance.
Chung O, Yao S, Yang F, Wang L, Cerda-Smith C, Hutchinson H bioRxiv. 2025; .
PMID: 40027615 PMC: 11870461. DOI: 10.1101/2025.02.18.638901.
Starble R, Sun E, Gbyli R, Radda J, Lu J, Jensen T bioRxiv. 2025; .
PMID: 39974875 PMC: 11838195. DOI: 10.1101/2025.01.26.634826.